Apic Bio (Global Rights for the Development and Commercialization of APB-102) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Apic Bio (Global Rights for the Development and Commercialization of APB-102) General Information

Description

Global rights for the development and commercialization of gene therapy drugs. The drug is comprised of a recombinant AAVrh10 vector that expresses a microribonucleic acid (miRNA) designed to knock down the expression of SOD1 with the goal of slowing down or potentially reversing the progression of ALS in patients with SOD1 mutations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Cambridge, MA
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
uniQure
Corporate Office
  • Cambridge, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apic Bio (Global Rights for the Development and Commercialization of APB-102) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Apic Bio (Global Rights for the Development and Commercialization of APB-102)‘s full profile, request access.

Request a free trial

Apic Bio (Global Rights for the Development and Commercialization of APB-102) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Apic Bio (Global Rights for the Development and Commercialization of APB-102)‘s full profile, request access.

Request a free trial

Apic Bio (Global Rights for the Development and Commercialization of APB-102) FAQs

  • Where is Apic Bio (Global Rights for the Development and Commercialization of APB-102) headquartered?

    Apic Bio (Global Rights for the Development and Commercialization of APB-102) is headquartered in Cambridge, MA.

  • What industry is Apic Bio (Global Rights for the Development and Commercialization of APB-102) in?

    Apic Bio (Global Rights for the Development and Commercialization of APB-102)’s primary industry is Buildings and Property.

  • Is Apic Bio (Global Rights for the Development and Commercialization of APB-102) a private or public company?

    Apic Bio (Global Rights for the Development and Commercialization of APB-102) is a Private company.

  • What is the current valuation of Apic Bio (Global Rights for the Development and Commercialization of APB-102)?

    The current valuation of Apic Bio (Global Rights for the Development and Commercialization of APB-102) is .

  • What is Apic Bio (Global Rights for the Development and Commercialization of APB-102)’s current revenue?

    The current revenue for Apic Bio (Global Rights for the Development and Commercialization of APB-102) is .

  • Who are Apic Bio (Global Rights for the Development and Commercialization of APB-102)’s investors?

    Apic Bio has invested in Apic Bio (Global Rights for the Development and Commercialization of APB-102).

  • When was Apic Bio (Global Rights for the Development and Commercialization of APB-102) acquired?

    Apic Bio (Global Rights for the Development and Commercialization of APB-102) was acquired on 31-Jan-2023.

  • Who acquired Apic Bio (Global Rights for the Development and Commercialization of APB-102)?

    Apic Bio (Global Rights for the Development and Commercialization of APB-102) was acquired by uniQure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process